|
ATP9A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.60300000001867E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.8942999999998E-05 |
| Normal-vs-Stage2 |
1.222020E-02 |
| Normal-vs-Stage3 |
1.91920000000012E-05 |
| Normal-vs-Stage4 |
3.92510000000179E-05 |
| Stage1-vs-Stage2 |
7.216600E-01 |
| Stage1-vs-Stage3 |
3.850600E-01 |
| Stage1-vs-Stage4 |
1.922420E-01 |
| Stage2-vs-Stage3 |
3.544000E-01 |
| Stage2-vs-Stage4 |
2.015800E-01 |
| Stage3-vs-Stage4 |
5.092600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.35230000003683E-06 |
| Normal-vs-AfricanAmerican |
1.134830E-01 |
| Normal-vs-Asian |
2.278300E-03 |
| Caucasian-vs-AfricanAmerican |
2.225200E-01 |
| Caucasian-vs-Asian |
7.573400E-01 |
| AfricanAmerican-vs-Asian |
3.813000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.21179999999599E-05 |
| Normal-vs-Female |
2.26199999999732E-05 |
| Male-vs-Female |
3.225800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.628700E-04 |
| Normal-vs-Age(41-60Yrs) |
4.32150000000409E-05 |
| Normal-vs-Age(61-80Yrs) |
1.84609999999141E-05 |
| Normal-vs-Age(81-100Yrs) |
8.843300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.187000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.954030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.014000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.459800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.287600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.872000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.137400E-01 |
| Classical-VS-Follicular |
7.335400E-03 |
| Classical-VS-Other |
3.747800E-01 |
| Classical-VS-Normal |
3.829000E-04 |
| Tall-VS-Follicular |
5.818600E-01 |
| Tall-VS-Other |
7.824600E-01 |
| Tall-VS-Normal |
3.775500E-04 |
| Follicular-VS-Other |
9.905400E-01 |
| Follicular-VS-Normal |
3.53750000003927E-06 |
| Other-VS-Normal |
4.963900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83765999999252E-05 |
| Normal-vs-N1 |
6.37310000000113E-05 |
| N0-vs-N1 |
2.807000E-01 |
|
|
